Let’s Communicate Cancer

BOPA are delighted to announce that their cancer training programme for pharmacy staff, Let’s Communicate Cancer, has been detailed in the recently released community Pharmacy Quality Scheme for 22/23.  This means that all patient facing pharmacy staff will access the e-learning via BOPA or the E-learning -for-health websites and complete Module 1 which looks at encouraging pharmacy participation in early diagnosis of cancer.  The target audience is approximately 40,000 staff and it is hoped that subsequent interventions will help early cancer  diagnosis and ultimately save lives.   Information can be found here: PSNC-Briefing-031.22-PQS-Summary-of-the-training-requirements-for-the-PQS-2022-23.pdf

Latest News

By Joseph Williams on 8th June 2026

BOPA and Pharmaceutical Journal (PJ) Collaboration – Advanced therapy medicinal products: a tsunami in clinical medicine (By BOPA Member – Nisha Shaunak)

This article is brought to you as part of a collaboration with the Pharmaceutical Journal (PJ). The views expressed in this article are those of the author and are not…

Read article
By BOPA E&T Subcommittee on 4th June 2026

SAVE THE DATE: BOPA Introduction to Cancer Course, London, September 2026 – Registration opens soon!

The popular Introduction to Cancer Course is coming to London in September 2026 The BOPA Introduction to Cancer Course 2026 WHEN: Thursday 17th & Friday 18th September 2026 WHERE: University College Hospital,…

Read article
By Macmillan Cancer Support on 4th June 2026

Cancer Information Development team at Macmillan Cancer Support

Dear BOPA members, The Cancer Information Development team at Macmillan Cancer Support would like to make you aware of a couple of new cancer treatment information pages on our website:…

Read article
By Clayton Wong on 1st June 2026

Launch of Bespoke Health Technology Assessment Course

Bespoke CPD Course on Health Technology Assessment (HTA)    We are delighted to see the launch of the BOPA Health Technology Assessment (HTA) course, which represents an important step forward in supporting the cancer pharmacy workforce…

Read article